iStock Rating

B
Details...
Enter Symbol click to research

JAZZ (NASDAQ: JAZZ)

Sector: Medical

Current Price : $58.41

52 Week Low
$41.23
52 Week High
$60.00
 

Company

Company Profile

Community


Analysis

Blog Articles
 

Charts

Technical Charts

Analyst

Analyst Ratings

Ratios

Technicals
 

JAZZ PHARM(NSDQ:JAZZ)
# Employees: 610
Address: 4TH FLOOR CONNAUGHT HOUSE ONE BURLINGTON ROAD,DUBLIN,L2,USA
Phone: 353-1-634-4183
Fax: 353 1 634 7850
Website: www.jazzpharmaceuticals.com
Email: investorinfo@jazzpharma.com
Sector: Medical
Industry: MED-DRUGS
Executive Officers
Bruce C. Cozadd (Chairman;ChiefExecutiveOfficerand Director)
Kathryn E. Falberg (Executive VicePresidentandChiefFinancial Officer)
Karen J. Wilson (Senior Vice President; Finance)
Paul L. Berns (Director)
Patrick G. Enright (Director,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 12/31/2012
Next Earnings Date(Expected): 5/7/2013
Mean EPS (Next Qtr): $1.30
Mean EPS (Year): $5.45
Mean Estimate(Long Term): $25.26
P/E Ratio(Based on EPS estimate): 10.100
Number of Estimates: 5
Shares Performance
Period jazz Compare to S&P
YTD 3.36 % -5.22 %
4 Weeks -3.40 % -3.30 %
12 Weeks -4.03 % -7.25 %
Shares Information
Analyst Coverage: Y
Avg Volume: 611872
Shares Outstanding: 58M
Market Cap: $3.19B
52 Week High: $60.00
52 Week Low: $41.23
P/E Ratio: 12.370
PEG Ratio: 0.400
Split: On 1/1/1990 jazz split by factor of 0.030
Earnings Performance
EPS Growth in Last Quarter: 16.81 %
EPS Growth in Last Year: 44.79 %
Sales Growth in Last Quarter: 4.67 %
Sales Growth in Last Quarter: 119.91 %
Financials
Qtr Book Value: $2.84
Cash Flow/Share: $9.33
Change in Payout Ratio: -0.010
Price/Sales: -0.010
Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia. Advertisement partners Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.